Profile for Agenus Inc. (AGEN)

$ 2.99   -0.05 (-1.64%) Volume: 675.05k 4:00 PM EDT Sep 16, 2019
After Hours:  $ 2.99 0.00 (0.00%) Volume: 166.98k 4:19 PM EDT Sep 16, 2019
Business Description:
Agenus Inc along with its subsidiaries is a pharmaceutical company. It is engaged in discovery and development of revolutionary new treatments that engage the body's immune system to benefit patients suffering from cancer.
Address: 3 Forbes Road, Lexington, MA, USA, 02421-7305
Telephone: +1 781 674-4400 Website:
Facsimile: +1 781 674-4200 Email: [email protected]
CEO: Garo H Armen
Employees: 294 Market Cap: 410.57m
Issue Type: CS
Auditor: KPMG LLP
Last Audit: Unqualified Opinion with Explanation
Indices: Biotechnology, Morningstar US Market Factor Tilt PR USD, Morningstar US Market Factor Tilt TR USD
Industry Classifications
Sector: Healthcare CIK: 1098972
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Biological Products, Except Diagnostic Substances (2836)